The pharmaceutical market has a renewed interest in gathering market insights as a component of their drug and therapy merchandizing plans. With regulatory changes, and the rise of the generic market, pharmaceutical manufacturers are placing greater emphasis on the go-to-market stage of new products to optimize their chances of delivering the next blockbuster. The complexity of the marketing research has grown alongside the complexity of regulatory requirements.
In this environment, Macromill and CareNet will jointly offer market research services tailored for the medical market. Macromill-CareNet will fuse the deep research expertise of Macromill with the highly curated physician panel from CareNet to deliver the complex studies pharma companies require to grow their business.
States Global CEO Han de Groot: “We are significantly expanding our internet based doctor and patient panels for our pharmaceutical clients in Japan. We will work closely with our global pharmaceutical clients to determine the footprint of our medical insights services beyond Japan.”
Macromill-CareNet will be led by Chairman Sekiguchi NobuYasushi, and President: Yoshiro Morohashi with offices in Tokyo.
CareNet operates a membership portal at carenet.com where doctors and health care workers may participate in marketing research. This represents a doctor/member panel of more than 12 million. CareNet offers services to support the sales and marketing activities of pharmaceutical companies in Japan.
Recently merged with MetrixLab, Macromill is a global provider of consumer insights and marketing analytics. Macromill turns data from online surveys, social media and enterprise systems into valuable business information and actionable consumer insights that help leading companies drive product innovation, brand engagement and customer value. Headquartered in Tokyo and Rotterdam with 25 offices across the Americas, Europe and Asia, Macromill provides analytics and insights services in more than 80 countries.